PreprintCC BYResearch Square
Prevalence, Clinical Presentation Antifungal Susceptibility Profiles and Factors Associated with Chronic Pulmonary Aspergillosis among Pulmonary Tuberculosis Suspects in Uganda: A Cross- sectional study
Related
- COVID-19-associated pulmonary aspergillosis: clinical characteristics, species distribution, environmental fungal contamination, and antifungal susceptibility
- Effects of Antifungal Treatment in COVID-19-Associated Pulmonary Aspergillosis A European Multicenter Cohort Study
- Species Distribution, Antifungal Susceptibility, and Factors Associated with Recurrence in Vulvovaginal Candidiasis
- Species Distribution, Antifungal Susceptibility, and Machine Learning-Based Prediction of Optimal Therapies Against Candida Species
- Molecular identification and antifungal susceptibility of otomycosis agents in Shiraz, Iran: predominance of Aspergillus tubingensis
BibTeX
@misc{anon2026prevalence,
title = {{Prevalence, Clinical Presentation Antifungal Susceptibility Profiles and Factors Associated with Chronic Pulmonary Aspergillosis among Pulmonary Tuberculosis Suspects in Uganda: A Cross- sectional study}},
howpublished = {Research Square},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13692608},
note = {CC BY},
}
RIS
TY - UNPB
TI - Prevalence, Clinical Presentation Antifungal Susceptibility Profiles and Factors Associated with Chronic Pulmonary Aspergillosis among Pulmonary Tuberculosis Suspects in Uganda: A Cross- sectional study
PY - 2026
DA - 2026/10/08
PB - Research Square
UR - https://europepmc.org/article/PMC/PMC13692608
SN - 2693-5015
ER -